The NIH 4D Nucleome program released a new wave of findings focused on how genome organization in space and time influences gene regulation, spanning multiple diseases and human aging biology. Researchers published a collection of papers in Science and Science Advances, using single-cell level multi-omics measurements to connect 3D chromatin changes and DNA methylation to cell state transitions. The reported work includes disease-focused analysis across heart disease, Alzheimer’s disease, brain aging, retinal health, and immune cell development, positioning genome architecture as an active regulatory layer rather than a static feature. The program’s approach is especially relevant to translational biotech because it offers a more granular view of regulatory programs that could be targeted in drug discovery—while also improving how biomarkers might be derived from cell context. For the industry, the update reinforces that government-funded consortia are continuing to generate foundational datasets and methods that can accelerate target validation and mechanism research.